{
  "@context": "https://schema.org",
  "@type": "DataCatalogItem",
  "name": "Interface 1S9P_5",
  "description": "Protein-protein interaction interface between chains nan and nan",
  "identifier": "1S9P_5",
  "mainEntity": {
    "@context": "https://schema.org",
    "@type": "Protein",
    "@id": "#protein_1S9P",
    "dct:conformsTo": "https://bioschemas.org/profiles/Protein/0.11-RELEASE",
    "identifier": "1S9P",
    "name": "Protein 1S9P",
    "description": "Protein structure with PDB ID: 1S9P. Part of the ELIXIR 3D-BioInfo benchmark dataset. This protein participates in interface 1S9P_5 as a homodimer.",
    "url": "https://www.rcsb.org/structure/1S9P",
    "taxonomicRange": {
      "@type": "DefinedTerm",
      "name": "Mus musculus",
      "inDefinedTermSet": "https://www.ncbi.nlm.nih.gov/taxonomy",
      "termCode": "10090",
      "url": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090"
    },
    "alternateName": [
      "PDB 1S9P",
      "Protein ID 1S9P"
    ],
    "hasRepresentation": [
      {
        "@type": "PropertyValue",
        "name": "PDB Structure",
        "value": "https://raw.githubusercontent.com/vibbits/Elixir-3DBioInfo-Benchmark-Protein-Interfaces/main/benchmark/benchmark_pdb_format/1s9p_5.pdb.gz",
        "description": "Compressed PDB format structure file"
      },
      {
        "@type": "PropertyValue",
        "name": "mmCIF Structure",
        "value": "https://raw.githubusercontent.com/vibbits/Elixir-3DBioInfo-Benchmark-Protein-Interfaces/main/benchmark/benchmark_mmcif_format/1s9p.cif.gz",
        "description": "Compressed mmCIF format structure file"
      },
      {
        "@type": "PropertyValue",
        "name": "PDB ID",
        "value": "1S9P",
        "description": "RCSB PDB identifier"
      }
    ],
    "additionalProperty": [
      {
        "@type": "PropertyValue",
        "name": "PDB_ID",
        "value": "1S9P",
        "description": "Protein Data Bank identifier (4 letters)"
      },
      {
        "@type": "PropertyValue",
        "name": "AssociatedInterface",
        "value": "1S9P_5",
        "description": "Interface this protein participates in"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceSource",
        "value": "QSalign",
        "description": "Source of interface ID: QSalign"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceChains",
        "value": "nan-nan",
        "description": "Chains involved in the interface"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceClassification",
        "value": "Non-physiological",
        "description": "Classification of the associated interface"
      },
      {
        "@type": "PropertyValue",
        "name": "LabelInterfaceChains",
        "value": "A-D",
        "description": "Chains involved in the assembly interface"
      },
      {
        "@type": "PropertyValue",
        "name": "Gene",
        "value": "Esrrg",
        "description": "Gene name associated with the protein"
      },
      {
        "@type": "PropertyValue",
        "name": "Superfamily",
        "value": "1.10.565.10",
        "description": "Protein superfamily classification"
      },
      {
        "@type": "PropertyValue",
        "name": "Pfam",
        "value": "PF00104",
        "description": "Pfam domain classification"
      },
      {
        "@type": "PropertyValue",
        "name": "PDBStructureMetadata",
        "description": "Structural metadata from RCSB Protein Data Bank",
        "value": "{\"pdb_id\": \"1S9P\", \"structure_metadata\": {\"pdb_id\": \"1S9P\", \"resolution\": 2.13, \"deposition_date\": \"2004-02-05T00:00:00+0000\", \"release_date\": \"2004-06-08T00:00:00+0000\", \"experimental_method\": null, \"source_organism\": [\"Mus musculus\"], \"citation\": {\"title\": \"Structural Basis for the Deactivation of the Estrogen-related Receptor {gamma} by Diethylstilbestrol or 4-Hydroxytamoxifen and Determinants of Selectivity.\", \"doi\": \"10.1074/jbc.M402195200\", \"authors\": [\"Greschik, H.\", \"Flaig, R.\", \"Renaud, J.P.\", \"Moras, D.\"]}, \"entity_count\": 3, \"r_factor\": null, \"space_group\": null, \"unit_cell\": {\"a\": 71.999, \"b\": 77.46, \"c\": 95.773, \"alpha\": 90.0, \"beta\": 97.55, \"gamma\": 90.0}, \"found_in_api\": true, \"sequences\": {\"A\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\", \"B\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\", \"C\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\", \"D\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\"}, \"chain_info\": {\"A\": {\"entity_id\": \"1\", \"organism\": \"Mus musculus\", \"sequence_length\": 227, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}, \"B\": {\"entity_id\": \"1\", \"organism\": \"Mus musculus\", \"sequence_length\": 227, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}, \"C\": {\"entity_id\": \"1\", \"organism\": \"Mus musculus\", \"sequence_length\": 227, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}, \"D\": {\"entity_id\": \"1\", \"organism\": \"Mus musculus\", \"sequence_length\": 227, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}}, \"entity_info\": {\"1\": {\"entity_id\": \"1\", \"sequence\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\", \"organism\": \"Mus musculus\", \"taxonomy_id\": 10090, \"chain_ids\": [\"A\", \"B\", \"C\", \"D\"], \"polymer_type\": \"polypeptide(L)\", \"sequence_length\": 227, \"gene_name\": null, \"uniprot_ids\": [\"P62509\"]}}, \"is_homomer\": true, \"sequence_clusters\": [{\"sequence\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\", \"entities\": [\"1\"], \"chain_count\": 4}], \"chain_ids\": [], \"entity_ids\": [\"1\", \"2\", \"3\"], \"polymer_composition\": \"homomeric protein\", \"homomer_type\": \"monomer\", \"homomer_chains\": 4, \"chain_count\": 4, \"unique_sequences\": 1, \"avg_sequence_length\": 227.0, \"min_sequence_length\": 227, \"max_sequence_length\": 227}, \"entity_metadata\": {\"1\": {\"entity_poly\": {\"nstd_linkage\": \"no\", \"nstd_monomer\": \"no\", \"pdbx_seq_one_letter_code\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\", \"pdbx_seq_one_letter_code_can\": \"KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV\", \"pdbx_strand_id\": \"A,B,C,D\", \"rcsb_artifact_monomer_count\": 0, \"rcsb_conflict_count\": 0, \"rcsb_deletion_count\": 0, \"rcsb_entity_polymer_type\": \"Protein\", \"rcsb_insertion_count\": 0, \"rcsb_mutation_count\": 0, \"rcsb_non_std_monomer_count\": 0, \"rcsb_sample_sequence_length\": 227, \"type\": \"polypeptide(L)\"}, \"entity_src_gen\": [{\"gene_src_common_name\": \"house mouse\", \"gene_src_genus\": \"Mus\", \"host_org_genus\": \"Escherichia\", \"host_org_species\": \"Escherichia coli\", \"pdbx_alt_source_flag\": \"sample\", \"pdbx_gene_src_gene\": \"ESRRG, NR3B3, ERRG2, ERR3, KIAA0832\", \"pdbx_gene_src_ncbi_taxonomy_id\": \"10090\", \"pdbx_gene_src_scientific_name\": \"Mus musculus\", \"pdbx_host_org_ncbi_taxonomy_id\": \"469008\", \"pdbx_host_org_scientific_name\": \"Escherichia coli BL21(DE3)\", \"pdbx_host_org_strain\": \"BL21(DE3)\", \"pdbx_host_org_vector_type\": \"plasmid\", \"pdbx_src_id\": 1, \"plasmid_name\": \"pET-15b\"}], \"rcsb_cluster_flexibility\": {\"avg_rmsd\": 1.948, \"label\": \"Low\", \"link\": \"http://pdbflex.org/cluster.html#!/2zbsA/10971/1s9pA\", \"max_rmsd\": 7.689, \"provenance_code\": \"PDBFlex\"}, \"rcsb_cluster_membership\": [{\"cluster_id\": 1856, \"identity\": 100}, {\"cluster_id\": 1932, \"identity\": 95}, {\"cluster_id\": 2204, \"identity\": 90}, {\"cluster_id\": 2517, \"identity\": 70}, {\"cluster_id\": 2813, \"identity\": 50}, {\"cluster_id\": 1714, \"identity\": 30}], \"rcsb_entity_host_organism\": [{\"ncbi_common_names\": [\"Escherichia coli str. BL21(DE3)\", \"Escherichia coli strain BL21(DE3)\"], \"ncbi_parent_scientific_name\": \"Bacteria\", \"ncbi_scientific_name\": \"Escherichia coli BL21(DE3)\", \"ncbi_taxonomy_id\": 469008, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Escherichia coli BL21(DE3)\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"131567\", \"name\": \"cellular organisms\"}, {\"depth\": 1, \"id\": \"131567\", \"name\": \"biota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria (ex Cavalier-Smith 1987)\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria Woese et al. 2024\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteriobiota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"eubacteria\"}, {\"depth\": 3, \"id\": \"3379134\", \"name\": \"Pseudomonadati\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Pseudomonadota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"\\\"Alphaproteobacteriota\\\" Whitman et al. 2018\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Alphaproteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"purple photosynthetic bacteria and relatives\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Gammaproteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Proteobacteria gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Pseudomonadia\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Purple bacteria, gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"g-proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subgroup\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacterales\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae and related endosymbionts\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae group\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriales\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteriaceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteraceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"enterobacteria\"}, {\"depth\": 8, \"id\": \"561\", \"name\": \"Escherichia\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacillus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli commune\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"E. coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Enterococcus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia/Shigella coli\"}, {\"depth\": 10, \"id\": \"469008\", \"name\": \"Escherichia coli BL21(DE3)\"}, {\"depth\": 10, \"id\": \"469008\", \"name\": \"Escherichia coli str. BL21(DE3)\"}, {\"depth\": 10, \"id\": \"469008\", \"name\": \"Escherichia coli strain BL21(DE3)\"}]}], \"rcsb_entity_source_organism\": [{\"common_name\": \"house mouse\", \"ncbi_common_names\": [\"house mouse\", \"mouse\"], \"ncbi_parent_scientific_name\": \"Eukaryota\", \"ncbi_scientific_name\": \"Mus musculus\", \"ncbi_taxonomy_id\": 10090, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Mus musculus\", \"source_type\": \"genetically engineered\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"131567\", \"name\": \"cellular organisms\"}, {\"depth\": 1, \"id\": \"131567\", \"name\": \"biota\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eukaryota\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eucarya\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eucaryotae\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eukarya\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eukaryotae\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"eukaryotes\"}, {\"depth\": 3, \"id\": \"33154\", \"name\": \"Opisthokonta\"}, {\"depth\": 3, \"id\": \"33154\", \"name\": \"Fungi/Metazoa group\"}, {\"depth\": 3, \"id\": \"33154\", \"name\": \"opisthokonts\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"Metazoa\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"Animalia\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"animals\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"metazoans\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"multicellular animals\"}, {\"depth\": 5, \"id\": \"6072\", \"name\": \"Eumetazoa\"}, {\"depth\": 6, \"id\": \"33213\", \"name\": \"Bilateria\"}, {\"depth\": 7, \"id\": \"33511\", \"name\": \"Deuterostomia\"}, {\"depth\": 7, \"id\": \"33511\", \"name\": \"deuterostomes\"}, {\"depth\": 8, \"id\": \"7711\", \"name\": \"Chordata\"}, {\"depth\": 8, \"id\": \"7711\", \"name\": \"chordates\"}, {\"depth\": 9, \"id\": \"89593\", \"name\": \"Craniata\"}, {\"depth\": 10, \"id\": \"7742\", \"name\": \"Vertebrata\"}, {\"depth\": 10, \"id\": \"7742\", \"name\": \"vertebrates\"}, {\"depth\": 11, \"id\": \"7776\", \"name\": \"Gnathostomata\"}, {\"depth\": 11, \"id\": \"7776\", \"name\": \"jawed vertebrates\"}, {\"depth\": 12, \"id\": \"117570\", \"name\": \"Teleostomi\"}, {\"depth\": 13, \"id\": \"117571\", \"name\": \"Euteleostomi\"}, {\"depth\": 13, \"id\": \"117571\", \"name\": \"bony vertebrates\"}, {\"depth\": 14, \"id\": \"8287\", \"name\": \"Sarcopterygii\"}, {\"depth\": 15, \"id\": \"1338369\", \"name\": \"Dipnotetrapodomorpha\"}, {\"depth\": 16, \"id\": \"32523\", \"name\": \"Tetrapoda\"}, {\"depth\": 16, \"id\": \"32523\", \"name\": \"tetrapods\"}, {\"depth\": 17, \"id\": \"32524\", \"name\": \"Amniota\"}, {\"depth\": 17, \"id\": \"32524\", \"name\": \"amniotes\"}, {\"depth\": 18, \"id\": \"40674\", \"name\": \"Mammalia\"}, {\"depth\": 18, \"id\": \"40674\", \"name\": \"mammals\"}, {\"depth\": 19, \"id\": \"32525\", \"name\": \"Theria\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"Eutheria\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"Placentalia\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"eutherian mammals\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"placental mammals\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"placentals\"}, {\"depth\": 21, \"id\": \"1437010\", \"name\": \"Boreoeutheria\"}, {\"depth\": 21, \"id\": \"1437010\", \"name\": \"Boreotheria\"}, {\"depth\": 22, \"id\": \"314146\", \"name\": \"Euarchontoglires\"}, {\"depth\": 23, \"id\": \"314147\", \"name\": \"Glires\"}, {\"depth\": 23, \"id\": \"314147\", \"name\": \"Rodents and rabbits\"}, {\"depth\": 24, \"id\": \"9989\", \"name\": \"Rodentia\"}, {\"depth\": 24, \"id\": \"9989\", \"name\": \"rodent\"}, {\"depth\": 24, \"id\": \"9989\", \"name\": \"rodents\"}, {\"depth\": 25, \"id\": \"1963758\", \"name\": \"Myomorpha\"}, {\"depth\": 25, \"id\": \"1963758\", \"name\": \"mice and others\"}, {\"depth\": 26, \"id\": \"337687\", \"name\": \"Muroidea\"}, {\"depth\": 27, \"id\": \"10066\", \"name\": \"Muridae\"}, {\"depth\": 28, \"id\": \"39107\", \"name\": \"Murinae\"}, {\"depth\": 29, \"id\": \"10088\", \"name\": \"Mus\"}, {\"depth\": 29, \"id\": \"10088\", \"name\": \"mice\"}, {\"depth\": 29, \"id\": \"10088\", \"name\": \"mouse\"}, {\"depth\": 30, \"id\": \"862507\", \"name\": \"Mus\"}, {\"depth\": 31, \"id\": \"10090\", \"name\": \"Mus musculus\"}, {\"depth\": 31, \"id\": \"10090\", \"name\": \"house mouse\"}, {\"depth\": 31, \"id\": \"10090\", \"name\": \"mouse\"}], \"rcsb_gene_name\": [{\"provenance_source\": \"Primary Data\", \"value\": \"ESRRG\"}, {\"provenance_source\": \"Primary Data\", \"value\": \"NR3B3\"}, {\"provenance_source\": \"Primary Data\", \"value\": \"ERRG2\"}, {\"provenance_source\": \"Primary Data\", \"value\": \"ERR3\"}, {\"provenance_source\": \"Primary Data\", \"value\": \"KIAA0832\"}]}], \"rcsb_genomic_lineage\": [{\"depth\": 1, \"id\": \"10090:1\", \"name\": \"Chromosome 1\"}, {\"depth\": 0, \"id\": \"10090\", \"name\": \"Mus musculus (mouse)\"}, {\"depth\": 2, \"id\": \"10090:1:estrogen_related_receptor_gamma\", \"name\": \"estrogen-related receptor gamma\"}], \"rcsb_polymer_entity\": {\"formula_weight\": 25.787, \"pdbx_description\": \"Estrogen-related receptor gamma\", \"pdbx_number_of_molecules\": 4, \"rcsb_multiple_source_flag\": \"N\", \"rcsb_source_part_count\": 1, \"rcsb_source_taxonomy_count\": 1, \"src_method\": \"man\", \"rcsb_macromolecular_names_combined\": [{\"name\": \"Estrogen-related receptor gamma\", \"provenance_code\": \"ECO:0000304\", \"provenance_source\": \"PDB Preferred Name\"}, {\"name\": \"Estrogen receptor related protein 3\", \"provenance_code\": \"ECO:0000303\", \"provenance_source\": \"PDB Synonym\"}, {\"name\": \"ERR gamma-2\", \"provenance_code\": \"ECO:0000303\", \"provenance_source\": \"PDB Synonym\"}], \"rcsb_polymer_name_combined\": {\"names\": [\"Estrogen-related receptor gamma\"], \"provenance_source\": \"UniProt Name\"}}, \"rcsb_polymer_entity_align\": [{\"provenance_source\": \"SIFTS\", \"reference_database_accession\": \"P62509\", \"reference_database_name\": \"UniProt\", \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 227, \"ref_beg_seq_id\": 232}]}], \"rcsb_polymer_entity_annotation\": [{\"annotation_id\": \"PF00104\", \"assignment_version\": \"34.0\", \"name\": \"Ligand-binding domain of nuclear hormone receptor (Hormone_recep)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"GO:0003707\", \"name\": \"nuclear steroid receptor activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0004879\", \"name\": \"nuclear receptor activity\"}, {\"id\": \"GO:0003707\", \"name\": \"nuclear steroid receptor activity\"}, {\"id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0060089\", \"name\": \"molecular transducer activity\"}, {\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0038023\", \"name\": \"signaling receptor activity\"}, {\"id\": \"GO:0098531\", \"name\": \"ligand-modulated transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0003677\", \"name\": \"DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR001723\", \"name\": \"Nuclear hormone receptor\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001723\", \"name\": \"Nuclear hormone receptor\"}]}, {\"annotation_id\": \"GO:0120162\", \"name\": \"positive regulation of cold-induced thermogenesis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0042592\", \"name\": \"homeostatic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:1990845\", \"name\": \"adaptive thermogenesis\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0048871\", \"name\": \"multicellular organismal-level homeostasis\"}, {\"id\": \"GO:0120161\", \"name\": \"regulation of cold-induced thermogenesis\"}, {\"id\": \"GO:0106106\", \"name\": \"cold-induced thermogenesis\"}, {\"id\": \"GO:0001659\", \"name\": \"temperature homeostasis\"}, {\"id\": \"GO:0120162\", \"name\": \"positive regulation of cold-induced thermogenesis\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0051240\", \"name\": \"positive regulation of multicellular organismal process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0051239\", \"name\": \"regulation of multicellular organismal process\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}]}, {\"annotation_id\": \"IPR003078\", \"name\": \"Retinoic acid receptor\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001723\", \"name\": \"Nuclear hormone receptor\"}, {\"depth\": 2, \"id\": \"IPR003078\", \"name\": \"Retinoic acid receptor\"}]}, {\"annotation_id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}]}, {\"annotation_id\": \"IPR001628\", \"name\": \"Zinc finger, nuclear hormone receptor-type\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001628\", \"name\": \"Zinc finger, nuclear hormone receptor-type\"}]}, {\"annotation_id\": \"GO:0034056\", \"name\": \"estrogen response element binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0043565\", \"name\": \"sequence-specific DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003690\", \"name\": \"double-stranded DNA binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0000977\", \"name\": \"RNA polymerase II transcription regulatory region sequence-specific DNA binding\"}, {\"id\": \"GO:0000987\", \"name\": \"cis-regulatory region sequence-specific DNA binding\"}, {\"id\": \"GO:1990837\", \"name\": \"sequence-specific double-stranded DNA binding\"}, {\"id\": \"GO:0000976\", \"name\": \"transcription cis-regulatory region binding\"}, {\"id\": \"GO:0034056\", \"name\": \"estrogen response element binding\"}, {\"id\": \"GO:0001067\", \"name\": \"transcription regulatory region nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0000978\", \"name\": \"RNA polymerase II cis-regulatory region sequence-specific DNA binding\"}]}, {\"annotation_id\": \"IPR013088\", \"name\": \"Zinc finger, NHR/GATA-type\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR013088\", \"name\": \"Zinc finger, NHR/GATA-type\"}]}, {\"annotation_id\": \"GO:0045893\", \"name\": \"positive regulation of DNA-templated transcription\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0045893\", \"name\": \"positive regulation of DNA-templated transcription\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0010557\", \"name\": \"positive regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0009891\", \"name\": \"positive regulation of biosynthetic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0010604\", \"name\": \"positive regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0051254\", \"name\": \"positive regulation of RNA metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:1902680\", \"name\": \"positive regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}]}, {\"annotation_id\": \"GO:0004879\", \"name\": \"nuclear receptor activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0004879\", \"name\": \"nuclear receptor activity\"}, {\"id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0060089\", \"name\": \"molecular transducer activity\"}, {\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0038023\", \"name\": \"signaling receptor activity\"}, {\"id\": \"GO:0098531\", \"name\": \"ligand-modulated transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0005516\", \"name\": \"calmodulin binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0005516\", \"name\": \"calmodulin binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR027289\", \"name\": \"Oestrogen-related receptor\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR024178\", \"name\": \"Estrogen receptor/oestrogen-related receptor\"}, {\"depth\": 2, \"id\": \"IPR027289\", \"name\": \"Oestrogen-related receptor\"}]}, {\"annotation_id\": \"GO:0005496\", \"name\": \"steroid binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0005496\", \"name\": \"steroid binding\"}, {\"id\": \"GO:0008289\", \"name\": \"lipid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0048384\", \"name\": \"retinoic acid receptor signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0030522\", \"name\": \"intracellular receptor signaling pathway\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048384\", \"name\": \"retinoic acid receptor signaling pathway\"}, {\"id\": \"GO:0009755\", \"name\": \"hormone-mediated signaling pathway\"}, {\"id\": \"GO:0035556\", \"name\": \"intracellular signal transduction\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0070887\", \"name\": \"cellular response to chemical stimulus\"}, {\"id\": \"GO:0009725\", \"name\": \"response to hormone\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0141193\", \"name\": \"nuclear receptor-mediated signaling pathway\"}, {\"id\": \"GO:0032870\", \"name\": \"cellular response to hormone stimulus\"}]}, {\"annotation_id\": \"IPR000536\", \"name\": \"Nuclear hormone receptor, ligand-binding domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR000536\", \"name\": \"Nuclear hormone receptor, ligand-binding domain\"}]}, {\"annotation_id\": \"GO:0008270\", \"name\": \"zinc ion binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043169\", \"name\": \"cation binding\"}, {\"id\": \"GO:0046914\", \"name\": \"transition metal ion binding\"}, {\"id\": \"GO:0008270\", \"name\": \"zinc ion binding\"}, {\"id\": \"GO:0043167\", \"name\": \"ion binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0046872\", \"name\": \"metal ion binding\"}, {\"id\": \"GO:0036094\", \"name\": \"small molecule binding\"}]}, {\"annotation_id\": \"IPR035500\", \"name\": \"Nuclear hormone receptor-like domain superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR035500\", \"name\": \"Nuclear hormone receptor-like domain superfamily\"}]}, {\"annotation_id\": \"GO:0045944\", \"name\": \"positive regulation of transcription by RNA polymerase II\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0045893\", \"name\": \"positive regulation of DNA-templated transcription\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0010557\", \"name\": \"positive regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0006366\", \"name\": \"transcription by RNA polymerase II\"}, {\"id\": \"GO:0009891\", \"name\": \"positive regulation of biosynthetic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0010604\", \"name\": \"positive regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0006357\", \"name\": \"regulation of transcription by RNA polymerase II\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0045944\", \"name\": \"positive regulation of transcription by RNA polymerase II\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0051254\", \"name\": \"positive regulation of RNA metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:1902680\", \"name\": \"positive regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}]}, {\"annotation_id\": \"GO:0001228\", \"name\": \"DNA-binding transcription activator activity, RNA polymerase II-specific\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0001228\", \"name\": \"DNA-binding transcription activator activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0001216\", \"name\": \"DNA-binding transcription activator activity\"}]}, {\"annotation_id\": \"GO:0005634\", \"name\": \"nucleus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043227\", \"name\": \"membrane-bounded organelle\"}, {\"id\": \"GO:0043229\", \"name\": \"intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0005622\", \"name\": \"intracellular anatomical structure\"}, {\"id\": \"GO:0043226\", \"name\": \"organelle\"}, {\"id\": \"GO:0005634\", \"name\": \"nucleus\"}, {\"id\": \"GO:0043231\", \"name\": \"intracellular membrane-bounded organelle\"}]}, {\"annotation_id\": \"GO:0000977\", \"name\": \"RNA polymerase II transcription regulatory region sequence-specific DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0043565\", \"name\": \"sequence-specific DNA binding\"}, {\"id\": \"GO:1990837\", \"name\": \"sequence-specific double-stranded DNA binding\"}, {\"id\": \"GO:0000976\", \"name\": \"transcription cis-regulatory region binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003690\", \"name\": \"double-stranded DNA binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0000977\", \"name\": \"RNA polymerase II transcription regulatory region sequence-specific DNA binding\"}, {\"id\": \"GO:0001067\", \"name\": \"transcription regulatory region nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"IPR024178\", \"name\": \"Estrogen receptor/oestrogen-related receptor\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR024178\", \"name\": \"Estrogen receptor/oestrogen-related receptor\"}]}, {\"annotation_id\": \"IPR050200\", \"name\": \"Nuclear hormone receptor family NR3 subfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR050200\", \"name\": \"Nuclear hormone receptor family NR3 subfamily\"}]}], \"rcsb_polymer_entity_container_identifiers\": {\"asym_ids\": [\"A\", \"B\", \"C\", \"D\"], \"auth_asym_ids\": [\"A\", \"B\", \"C\", \"D\"], \"chem_comp_monomers\": [\"ALA\", \"ARG\", \"ASN\", \"ASP\", \"CYS\", \"GLN\", \"GLU\", \"GLY\", \"HIS\", \"ILE\", \"LEU\", \"LYS\", \"MET\", \"PHE\", \"PRO\", \"SER\", \"THR\", \"TRP\", \"TYR\", \"VAL\"], \"entity_id\": \"1\", \"entry_id\": \"1S9P\", \"rcsb_id\": \"1S9P_1\", \"uniprot_ids\": [\"P62509\"], \"reference_sequence_identifiers\": [{\"database_accession\": \"P62509\", \"database_name\": \"UniProt\", \"entity_sequence_coverage\": 1.0, \"provenance_source\": \"SIFTS\", \"reference_sequence_coverage\": 0.49563318777292575}]}, \"rcsb_polymer_entity_feature\": [{\"assignment_version\": \"34.0\", \"feature_id\": \"PF00104\", \"name\": \"Ligand-binding domain of nuclear hormone receptor (Hormone_recep)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 24, \"end_seq_id\": 210}]}, {\"name\": \"Hydropathy values\", \"provenance_source\": \"biojava-7.2.4\", \"type\": \"hydropathy\", \"feature_positions\": [{\"beg_seq_id\": 5, \"values\": [-1.06, -0.2, 0.4, 1.01, 1.6, 1.64, 0.97, 0.11, -0.23, 0.62, 0.06, -0.17, -0.42, -0.8, -0.8, -0.8, -0.49, 0.41, -0.27, -0.51, -0.8, -1.4, -0.72, -0.77, -0.39, 0.11, -0.43, -0.33, 0.48, 0.84, 0.84, 0.77, 1.4, 0.81, -0.11, -0.42, 0.08, 0.12, 0.31, 1.2, 1.28, 1.03, 1.32, 2.02, 1.98, 1.2, 1.23, 0.59, 0.04, -0.14, -0.19, -0.17, 0.06, 0.4, 1.18, 0.88, 0.67, 0.32, 0.22, 0.22, 0.72, 0.72, 0.42, -0.09, -0.09, 0.2, 0.8, 0.2, 0.79, 0.79, 0.87, 1.68, 1.72, 1.99, 2.56, 2.2, 2.09, 1.5, 1.5, 0.91, 0.8, 0.46, -0.4, -1.26, -0.69, 0.28, 0.22, 0.0, -0.3, -1.0, -0.76, 0.13, 0.73, -0.08, -0.93, -1.18, -1.77, -1.47, -1.51, -0.94, -1.24, -1.5, -0.69, 0.12, 0.12, 0.93, 0.63, 0.68, 0.46, 0.76, 1.22, 0.41, 0.41, 1.27, 0.41, 0.37, 0.61, -0.02, -0.61, -0.82, -0.87, -0.87, -1.72, -1.72, -1.68, -1.92, -1.18, -0.62, -0.91, -0.06, -0.91, -0.32, 0.61, 1.2, 2.01, 1.9, 1.04, 1.03, 0.22, 0.57, 0.58, -0.28, 0.02, -0.79, -1.38, -0.52, -0.82, -0.23, 0.32, -0.28, -0.36, -0.43, -0.43, -0.43, -0.43, 0.38, -0.18, -1.03, -0.44, 0.41, -0.4, -0.4, -0.16, -1.01, -1.23, -0.92, -0.92, -1.48, -1.69, -1.69, -1.69, -1.72, -1.83, -2.53, -2.29, -1.94, -2.02, -2.02, -1.21, -0.61, -0.51, 0.41, 0.73, 0.96, 1.42, 1.36, 0.76, 0.26, -0.04, -0.04, -0.9, -0.52, -0.48, -1.29, -1.14, -0.44, -0.51, -0.81, -0.23, -0.23, -0.01, -0.87, -0.52, -0.6, -0.44, -0.48, 0.12, -0.73, -0.73, -0.73, -0.03, 0.43, 0.48, 0.22, 0.82, 0.22, 0.78, 0.78, 0.82]}]}, {\"name\": \"Disordered binding sites\", \"provenance_source\": \"Anchor2\", \"type\": \"disorder_binding\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.22, 0.24, 0.25, 0.26, 0.26, 0.26, 0.28, 0.28, 0.29, 0.29, 0.3, 0.29, 0.29, 0.28, 0.27, 0.27, 0.26, 0.25, 0.24, 0.24, 0.24, 0.23, 0.22, 0.22, 0.21, 0.2, 0.2, 0.2, 0.2, 0.2, 0.19, 0.19, 0.2, 0.21, 0.22, 0.22, 0.23, 0.22, 0.2, 0.18, 0.17, 0.16, 0.14, 0.12, 0.09, 0.08, 0.06, 0.05, 0.05, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.05, 0.05, 0.05, 0.05, 0.05, 0.05, 0.05, 0.05, 0.05, 0.04, 0.04, 0.03, 0.03, 0.03, 0.02, 0.02, 0.02, 0.02, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.02, 0.02, 0.02, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.08, 0.09, 0.1, 0.1, 0.1, 0.1, 0.09, 0.09, 0.09, 0.09, 0.09, 0.08, 0.08, 0.07, 0.07, 0.06, 0.06, 0.06, 0.06, 0.06, 0.06, 0.06, 0.06, 0.06, 0.07, 0.07, 0.08, 0.09, 0.1, 0.11, 0.12, 0.14, 0.16, 0.18, 0.2, 0.21, 0.23, 0.24, 0.26, 0.28, 0.3, 0.32, 0.32, 0.34, 0.35, 0.37, 0.4, 0.42, 0.43, 0.41, 0.41, 0.42, 0.42, 0.41, 0.42, 0.42, 0.43, 0.41, 0.4, 0.39, 0.38, 0.39, 0.39, 0.4, 0.41, 0.42, 0.43, 0.43, 0.41, 0.4, 0.38, 0.38, 0.38, 0.38, 0.38, 0.39, 0.39, 0.4, 0.4, 0.4, 0.41, 0.42, 0.41, 0.41, 0.41, 0.41, 0.4, 0.4, 0.39, 0.38, 0.37, 0.36, 0.35, 0.35, 0.35, 0.35, 0.35, 0.35, 0.36, 0.37, 0.38, 0.39, 0.4, 0.42, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.41, 0.41, 0.41, 0.41, 0.42, 0.43, 0.42, 0.41, 0.39, 0.37, 0.35, 0.34, 0.32, 0.32, 0.32, 0.34, 0.36, 0.4, 0.43, 0.41, 0.38, 0.36, 0.33, 0.3]}]}, {\"name\": \"Disordered regions\", \"provenance_source\": \"IUPred2(short)\", \"type\": \"disorder\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.8, 0.71, 0.65, 0.62, 0.61, 0.58, 0.53, 0.42, 0.31, 0.25, 0.18, 0.2, 0.2, 0.29, 0.28, 0.22, 0.31, 0.37, 0.37, 0.37, 0.34, 0.38, 0.41, 0.35, 0.34, 0.31, 0.21, 0.17, 0.25, 0.23, 0.22, 0.27, 0.24, 0.25, 0.15, 0.11, 0.11, 0.06, 0.03, 0.03, 0.02, 0.03, 0.03, 0.03, 0.02, 0.03, 0.03, 0.02, 0.03, 0.03, 0.03, 0.03, 0.01, 0.01, 0.01, 0.02, 0.02, 0.03, 0.02, 0.02, 0.02, 0.03, 0.03, 0.01, 0.01, 0.03, 0.01, 0.01, 0.01, 0.0, 0.0, 0.01, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.0, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.01, 0.01, 0.01, 0.02, 0.04, 0.06, 0.07, 0.07, 0.08, 0.06, 0.12, 0.06, 0.04, 0.03, 0.04, 0.06, 0.11, 0.12, 0.05, 0.03, 0.05, 0.06, 0.06, 0.05, 0.05, 0.03, 0.02, 0.02, 0.02, 0.04, 0.03, 0.03, 0.05, 0.09, 0.08, 0.08, 0.05, 0.05, 0.03, 0.06, 0.09, 0.05, 0.07, 0.06, 0.05, 0.06, 0.1, 0.11, 0.11, 0.11, 0.12, 0.12, 0.12, 0.13, 0.09, 0.1, 0.15, 0.16, 0.17, 0.25, 0.18, 0.22, 0.32, 0.3, 0.32, 0.36, 0.37, 0.35, 0.27, 0.27, 0.32, 0.23, 0.33, 0.29, 0.29, 0.36, 0.35, 0.34, 0.41, 0.4, 0.45, 0.53, 0.52, 0.49, 0.55, 0.61, 0.57, 0.49, 0.48, 0.55, 0.47, 0.49, 0.5, 0.42, 0.46, 0.47, 0.46, 0.46, 0.49, 0.48, 0.45, 0.35, 0.35, 0.35, 0.29, 0.2, 0.2, 0.15, 0.21, 0.16, 0.16, 0.23, 0.2, 0.18, 0.28, 0.23, 0.22, 0.22, 0.15, 0.09, 0.05, 0.06, 0.07, 0.04, 0.04, 0.05, 0.09, 0.05, 0.12, 0.15, 0.26, 0.3, 0.34, 0.38, 0.5, 0.51, 0.58, 0.62]}]}], \"rcsb_polymer_entity_feature_summary\": [{\"count\": 1, \"coverage\": 0.82379, \"type\": \"Pfam\"}], \"rcsb_polymer_entity_group_membership\": [{\"aggregation_method\": \"sequence_identity\", \"group_id\": \"2517_70\", \"similarity_cutoff\": 70.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 227, \"ref_beg_seq_id\": 275}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"1714_30\", \"similarity_cutoff\": 30.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 104, \"ref_beg_seq_id\": 397}, {\"entity_beg_seq_id\": 105, \"length\": 46, \"ref_beg_seq_id\": 502}, {\"entity_beg_seq_id\": 151, \"length\": 14, \"ref_beg_seq_id\": 553}, {\"entity_beg_seq_id\": 165, \"length\": 13, \"ref_beg_seq_id\": 570}, {\"entity_beg_seq_id\": 178, \"length\": 50, \"ref_beg_seq_id\": 587}]}, {\"aggregation_method\": \"matching_uniprot_accession\", \"group_id\": \"P62509\", \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 227, \"ref_beg_seq_id\": 232}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"1932_95\", \"similarity_cutoff\": 95.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 227, \"ref_beg_seq_id\": 232}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"2204_90\", \"similarity_cutoff\": 90.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 227, \"ref_beg_seq_id\": 275}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"2813_50\", \"similarity_cutoff\": 50.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 177, \"ref_beg_seq_id\": 286}, {\"entity_beg_seq_id\": 178, \"length\": 50, \"ref_beg_seq_id\": 467}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"1856_100\", \"similarity_cutoff\": 100.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 227, \"ref_beg_seq_id\": 232}]}], \"rcsb_polymer_entity_name_com\": [{\"name\": \"Estrogen receptor related protein 3, ERR gamma-2\"}], \"rcsb_related_target_references\": [{\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL3585238\", \"target_taxonomy_id\": 10090, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 226, \"target_beg_seq_id\": 232}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL4523738\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 226, \"target_beg_seq_id\": 232}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL4245\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 226, \"target_beg_seq_id\": 232}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P62508\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 226, \"target_beg_seq_id\": 232}]}, {\"related_resource_name\": \"Pharos\", \"related_resource_version\": \"6.13.4\", \"related_target_id\": \"757\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 226, \"target_beg_seq_id\": 232}]}], \"rcsb_target_cofactors\": [{\"binding_assay_value\": 4.19, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"GJOOJSKMPRJUDY-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC(=O)CCC(=C(c1ccc(O)cc1)c1ccc(O)cc1)c1ccccc1\", \"cofactor_resource_id\": \"CHEMBL4065193\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3585238\"}, {\"binding_assay_value\": 3.34, \"binding_assay_value_type\": \"pKd\", \"cofactor_in_ch_ikey\": \"LLEWMHCIOFGAJM-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)c1ccc(Cn2cc(-c3ccc(O)c(O)c3)nn2)cc1\", \"cofactor_resource_id\": \"CHEMBL3585698\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL4245\"}, {\"cofactor_in_ch_ikey\": \"GXPHKUHSUJUWKP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O\", \"cofactor_name\": \"Troglitazone\", \"cofactor_resource_id\": \"DB00197\", \"mechanism_of_action\": \"Troglitazone is a thiazolidinedione antidiabetic agent that lowers blood glucose by improving target cell response to insulin. It has a unique mechanism of action that is dependent on the presence of insulin for activity. Troglitazone decreases hepatic glucose output and increases insulin dependent glucose disposal in skeletal muscle. Its mechanism of action is thought to involve binding to nuclear receptors (PPAR) that regulate the transcription of a number of insulin responsive genes critical for the control of glucose and lipid metabolism. Troglitazone is a ligand to both PPAR\\u03b1 and PPAR\\u03b3, with a highter affinity for PPAR\\u03b3. The drug also contains an \\u03b1-tocopheroyl moiety, potentially giving it vitamin E-like activity. Troglitazone has been shown to reduce inflammation, and is associated with a decrase in nuclear factor kappa-B (NF-\\u03baB) and a concomitant increase in its inhibitor (I\\u03baB). Unlike sulfonylureas, troglitazone is not an insulin secretagogue.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [20298676], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"GZENKSODFLBBHQ-ILSZZQPISA-N\", \"cofactor_smiles\": \"[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C\", \"cofactor_name\": \"Medrysone\", \"cofactor_resource_id\": \"DB00253\", \"mechanism_of_action\": \"There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Initially, the drug binds to the glucocorticoid receptor in the cytosol. This migrates to the nucleus and binds to genetic elements which cause activation and repression of the involved genes in the inflammatory pathway.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"RGLYKWWBQGJZGM-ISLYRVAYSA-N\", \"cofactor_smiles\": \"CC\\\\C(=C(\\\\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1\", \"cofactor_chem_comp_id\": \"DES\", \"cofactor_name\": \"Diethylstilbestrol\", \"cofactor_resource_id\": \"DB00255\", \"mechanism_of_action\": \"Estrogens diffuse into their target cells and interact with a protein receptor, the estrogen receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. The effect of Estrogen binding their receptors causes downstream increases the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. The combination of an estrogen with a progestin suppresses the hypothalamic-pituitary system, decreasing the secretion of gonadotropin-releasing hormone (GnRH).\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [15161930, 10592235, 11297507], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"ILKJAFIWWBXGDU-MOGDOJJUSA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C\", \"cofactor_name\": \"Amcinonide\", \"cofactor_resource_id\": \"DB00288\", \"mechanism_of_action\": \"The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Amcinonide has affinity for the glucocorticoid receptor. It has weak affinity for the progesterone receptor, and virtually no affinity for the mineralocorticoid, estrogen, or androgen receptors.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"VWVSBHGCDBMOOT-IIEHVVJPSA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C\", \"cofactor_name\": \"Desoximetasone\", \"cofactor_resource_id\": \"DB00547\", \"mechanism_of_action\": \"The precise mechanism of the antiinflammatory activity of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. However, corticosteroids are thought to act by the induction of phospholipase A<sub>2</sub> inhibitory proteins, collectively called lipocortins. This is achieved first by the drug binding to the glucocorticoid receptors which then translocates into the nucleus and binds to DNA causing various activations and repressions of genes. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A<sub>2</sub>.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"LEHFPXVYPMWYQD-XHIJKXOTSA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C\", \"cofactor_name\": \"Ulobetasol\", \"cofactor_resource_id\": \"DB00596\", \"mechanism_of_action\": \"The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]\\r\\n\\r\\nGlucocorticoids inhibit phospholipase 2 and neutrophil apoptosis and demargination, resulting in decreased formation of arachidonic acid derivatives. They also inhibit NF-Kappa B and other inflammatory transcription factors while promoting anti-inflammatory genes like interleukin-10.[A215577,A187463]\\r\\n\\r\\nLower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"WXURHACBFYSXBI-GQKYHHCASA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C\", \"cofactor_name\": \"Flumethasone\", \"cofactor_resource_id\": \"DB00663\", \"mechanism_of_action\": \"Flumethasone is a glucocorticoid receptor agonist. This complex binds to the nucleus causing a variety of genetic activation and repressions. The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Flumethasone binds to plasma transcortin, and it becomes active when it is not bound to transcortin.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"NKANXQFJJICGDU-QPLCGJKRSA-N\", \"cofactor_smiles\": \"CC\\\\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"CTX\", \"cofactor_name\": \"Tamoxifen\", \"cofactor_resource_id\": \"DB00675\", \"mechanism_of_action\": \"Tamoxifen competitively inhibits estrogen binding to its receptor, which is critical for it's activity in breast cancer cells.[A1025] Tamoxifen leads to a decrease in tumor growth factor \\u03b1 and insulin-like growth factor 1, and an increase in sex hormone binding globulin.[A1025] The increase in sex hormon binding globulin limits the amount of freely available estradiol.[A1025] These changes reduce levels of factors that stimulate tumor growth.[A1025]\\r\\n\\r\\nTamoxifen has also been shown to induce apoptosis in estrogen receptor positive cells.[A182195] This action is thought to be the result of inhibition of protein kinase C, which prevents DNA synthesis.[A182195] Alternate theories for the apoptotic effect of tamoxifen comes from the approximately 3 fold increase in intracellular and mitochondrial calcium ion levels after administration or the induction of tumor growth factor \\u03b2.[A182195]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [16889744], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"POPFMWWJOGLOIF-XWCQMRHXSA-N\", \"cofactor_smiles\": \"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO\", \"cofactor_name\": \"Flurandrenolide\", \"cofactor_resource_id\": \"DB00846\", \"mechanism_of_action\": \"Flurandrenolide is a topical corticosteroid.  It is normally applied to a plastic tape called Cordran.  Cordran is primarily effective because of its anti-inflammatory, antipruritic, and vasoconstrictive actions. Flurandrenolide, which is slowly released from the Cordran tape, binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. Cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In another words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.  Like other glucocorticoid agents Fluocinolone acetonide acts as a physiological antagonist to insulin by decreasing glycogenesis (formation of glycogen).  It also promotes the breakdown of lipids (lipolysis), and proteins, leading to the mobilization of extrahepatic amino acids and ketone bodies. This leads to increased circulating glucose concentrations (in the blood). There is also decreased glycogen formation in the liver.\\r\\n\\r\\n\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"DMKSVUSAATWOCU-HROMYWEYSA-N\", \"cofactor_smiles\": \"[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C\", \"cofactor_name\": \"Loteprednol etabonate\", \"cofactor_resource_id\": \"DB14596\", \"mechanism_of_action\": \"Corticosteroids like loteprednol etabonate inhibit the inflammatory response to a variety of inciting agents and likely delay or slow healing [FDA Label, L4539, A1312]. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation that are commonly associated with inflammation [FDA Label, A1312]. While glucocorticoids are known to bind to and activate the glucocorticoid receptor, the molecular mechanisms involved in glucocorticoid/glucocorticoid receptor-dependent modulation of inflammation are not clearly established [FDA Label, L4539, A1312]. Moreover, corticosteroids are thought to inhibit prostaglandin production through several independent mechanisms [FDA Label, A1312]. In particular, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins [F1467]. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid [F1467]. Arachidonic acid is released from membrane phospholipids by phospholipase A2 [F1467].  \\r\\n\\r\\nThe use of LE subsequently treats post-operative inflammation and pain following ocular surgery by managing the prostaglandin release, recruitment and travel of neutrophils and macrophages, and production of other inflammatory mediators that are intrinsically associated with the physical trauma of surgery [A1312].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"AUJRCFUBUPVWSZ-XTZHGVARSA-M\", \"cofactor_smiles\": \"CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O\", \"cofactor_name\": \"Auranofin\", \"cofactor_resource_id\": \"DB00995\", \"mechanism_of_action\": \"Inflammatory arthritis can cause joint swelling, warmth, pain, and tenderness; one cause of this condition is rheumatoid arthritis.[L32358] In patients with rheumatoid arthritis, gold salts such as auranofin can be administered to decrease joint inflammation and prevent the destruction of bones and cartilage. Though the mechanism of action of auranofin is not fully established in rheumatoid arthritis, this drug has been shown to inhibit phagocytosis and the release of antibodies and enzymes that play a role in cytotoxic reactions, suppressing the inflammatory response.[A230888,A230968] \\r\\n\\r\\nAside from its probable immune effects in inflammatory arthritis, studies have shown that auranofin inhibits thioredoxin reductase. This enzyme has various roles in cell homeostasis, including the regulation of free radicals.[A230888,A230928] Thioredoxin reductase can be over expressed in various types of tumours, rendering it an attractive target for anticancer drug development.[A230943] Studies have shown that inhibiting thioredoxin reductase can cause oxidative stress and apoptosis of tumour cells by increasing the formation of free radicals. Aurofin's thiol ligand binds with high affinity to thiol and selenol groups, forming irreversible reaction products.[A230888] One study showed that treatment with auranofin increased the production or reactive oxygen species and caused elevation of intracellular calcium concentration in platelets, leading to cell death.[A230943] Another study showed that auranofin enhanced the production of free radicals, governing T-cell activation.[A230893]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"WJOHZNCJWYWUJD-IUGZLZTKSA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O\", \"cofactor_name\": \"Fluocinonide\", \"cofactor_resource_id\": \"DB01047\", \"mechanism_of_action\": \"Fluocinonide is a potent glucocorticoid steroid used topically as anti-inflammatory agent for the treatment of skin disorders such as eczema. Fluocinonide binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. Cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In another words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.  Like other glucocorticoid agents Fluocinolone acetonide acts as a physiological antagonist to insulin by decreasing glycogenesis (formation of glycogen). It also promotes the breakdown of lipids (lipolysis), and proteins, leading to the mobilization of extrahepatic amino acids and ketone bodies. This leads to increased circulating glucose concentrations (in the blood). There is also decreased glycogen formation in the liver.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"FNPXMHRZILFCKX-KAJVQRHHSA-N\", \"cofactor_smiles\": \"[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C\", \"cofactor_name\": \"Prednicarbate\", \"cofactor_resource_id\": \"DB01130\", \"mechanism_of_action\": \"In common with other topical corticosteroids, prednicarbate has anti-inflammatory, antipruritic, and vasoconstrictive properties. In general, the mechanism of the anti-inflammatory activity of topical steroids is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"WBGKWQHBNHJJPZ-LECWWXJVSA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C\", \"cofactor_name\": \"Desonide\", \"cofactor_resource_id\": \"DB01260\", \"mechanism_of_action\": \"Like other topical corticosteroids, desonide has anti-inflammatory, antipruritic and vasoconstrictive properties. The drug binds to cytosolic glucocorticoid receptors. This complex migrates to the nucleus and binds to genetic elements on the DNA. This activates and represses various genes. However corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"ITRJWOMZKQRYTA-RFZYENFJSA-N\", \"cofactor_smiles\": \"[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C\", \"cofactor_name\": \"Cortisone acetate\", \"cofactor_resource_id\": \"DB01380\", \"mechanism_of_action\": \"The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]\\r\\nGlucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]\\r\\nLower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"BHQCQFFYRZLCQQ-OELDTZBJSA-N\", \"cofactor_smiles\": \"[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C\", \"cofactor_chem_comp_id\": \"CHD\", \"cofactor_name\": \"Cholic Acid\", \"cofactor_resource_id\": \"DB02659\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"TXUZVZSFRXZGTL-QPLCGJKRSA-N\", \"cofactor_smiles\": \"CC\\\\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"OHT\", \"cofactor_name\": \"Afimoxifene\", \"cofactor_resource_id\": \"DB04468\", \"mechanism_of_action\": \"Afimoxifene binds to estrogen receptors (ER), inducing a conformational change in the receptor. This results in a blockage or change in the expression of estrogen dependent genes. \", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"MUQNGPZZQDCDFT-JNQJZLCISA-N\", \"cofactor_smiles\": \"[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C\", \"cofactor_name\": \"Halcinonide\", \"cofactor_resource_id\": \"DB06786\", \"mechanism_of_action\": \"The precise mechanism of action of topical corticosteroids is unclear. However they possess anti-inflammatory, antipruritic, and vasoconstrictive actions.\\r\\n\\r\\nNew research indicates that halcinonide activates MBP (myelin basic protein) expression via smoothened receptor activation. This finding suggests that halcinonide could be used in the treatment of multiple sclerosis therapy as an alternative to Dexamethasone or Methylprednisolone. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"MFDXHRPPSJRQFX-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)C1=CC=C(CNNC(=O)C2=CC=C(O)C=C2)C=C1\", \"cofactor_chem_comp_id\": \"1BA\", \"cofactor_name\": \"4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE\", \"cofactor_resource_id\": \"DB06884\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"QBDSZLJBMIMQRS-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)(C1=CC=CC=C1)C1=CC=C(O)C=C1\", \"cofactor_chem_comp_id\": \"1OH\", \"cofactor_name\": \"p-Cumylphenol\", \"cofactor_resource_id\": \"DB06902\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"IISBACLAFKSPIT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1\", \"cofactor_chem_comp_id\": \"2OH\", \"cofactor_name\": \"Bisphenol A\", \"cofactor_resource_id\": \"DB06973\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"SDDLEVPIDBLVHC-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(O)C=C1\", \"cofactor_chem_comp_id\": \"BPZ\", \"cofactor_name\": \"Bisphenol Z\", \"cofactor_resource_id\": \"DB07485\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"FHXBMXJMKMWVRG-SLHNCBLASA-N\", \"cofactor_smiles\": \"[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(OC(C)=O)C=C3CC[C@@]21[H]\", \"cofactor_name\": \"Estradiol acetate\", \"cofactor_resource_id\": \"DB13952\", \"mechanism_of_action\": \"Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.\\r\\n\\r\\nIncreases in the down-stream effects of ER binding reverses some of the symptoms of menopause, which are primarily caused by a loss of estrogenic activity. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [22935422], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"UYIFTLBWAOGQBI-BZDYCCQFSA-N\", \"cofactor_smiles\": \"[H][C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(OC(=O)C5=CC=CC=C5)=CC=C4[C@@]3([H])CC[C@]12C\", \"cofactor_name\": \"Estradiol benzoate\", \"cofactor_resource_id\": \"DB13953\", \"mechanism_of_action\": \"Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [22935422], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"UOACKFBJUYNSLK-XRKIENNPSA-N\", \"cofactor_smiles\": \"[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1\", \"cofactor_name\": \"Estradiol cypionate\", \"cofactor_resource_id\": \"DB13954\", \"mechanism_of_action\": \"Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.\\r\\n\\r\\nIncreases in the down-stream effects of ER binding reverses some of the symptoms of menopause and of hypoestrogenism, which are primarily caused by a loss of estrogenic activity. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [22935422], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"OVAHZPTYWMWNKO-CAHAWPIUSA-N\", \"cofactor_smiles\": \"CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C\", \"cofactor_name\": \"Estradiol dienanthate\", \"cofactor_resource_id\": \"DB13955\", \"mechanism_of_action\": \"Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [22935422], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"cofactor_in_ch_ikey\": \"RSEPBGGWRJCQGY-RBRWEJTLSA-N\", \"cofactor_smiles\": \"[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3\", \"cofactor_name\": \"Estradiol valerate\", \"cofactor_resource_id\": \"DB13956\", \"mechanism_of_action\": \"Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.\\r\\n\\r\\nIncreases in the down-stream effects of ER binding reverses some of the symptoms of menopause, which are primarily caused by a loss of estrogenic activity. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [22935422], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P62508\"}, {\"binding_assay_value\": 8.31, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1\", \"cofactor_chem_comp_id\": \"2OH\", \"cofactor_resource_id\": \"CHEMBL418971\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [28882502], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 8.22, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3ccc(O)cc3)cc2)CC1.Cl.Cl\", \"cofactor_resource_id\": \"CHEMBL4436391\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [30657313], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 7.77, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"Cc1ccc(/C(=C(\\\\\\\\CCCO)c2ccccc2)c2ccc(N3CCN(C(C)C)CC3)cc2)cc1.Cl.Cl\", \"cofactor_resource_id\": \"CHEMBL4437929\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [30657313], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 7.75, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CCN1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3ccc(C)cc3)cc2)CC1.Cl.Cl\", \"cofactor_resource_id\": \"CHEMBL4580171\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [30657313], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 7.75, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3cccc(Br)c3)cc2)CC1.Cl.Cl\", \"cofactor_resource_id\": \"CHEMBL4579002\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [30657313], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 7.7, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3cccc(O)c3)cc2)CC1.Cl.Cl\", \"cofactor_resource_id\": \"CHEMBL4451327\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [30657313], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 7.7, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3cccc(O)c3)cc2)CC1\", \"cofactor_resource_id\": \"CHEMBL4597874\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [32758860], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 7.68, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CC(C)N1CCN(c2ccc(/C(=C(/CCCO)c3ccccc3)c3ccc(Br)cc3)cc2)CC1.Cl.Cl\", \"cofactor_resource_id\": \"CHEMBL4541589\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [30657313], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}, {\"binding_assay_value\": 7.11, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CN(C)CCOc1ccc(/C(=C(/CCCO)c2ccccc2)c2ccc(O)cc2)cc1\", \"cofactor_chem_comp_id\": \"TXF\", \"cofactor_resource_id\": \"CHEMBL201013\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [32758860], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"757\"}], \"rcsb_id\": \"1S9P_1\"}}, \"interface_chains\": {\"chain1\": \"nan\", \"chain2\": \"nan\", \"assembly_chain1\": \"A\", \"assembly_chain2\": \"D\"}, \"enrichment_timestamp\": \"2025-12-21T10:50:03.946279\"}",
        "valueReference": {
          "@type": "PropertyValue",
          "name": "ParsedPDBMetadata",
          "value": {
            "resolution": 2.13,
            "experimentalMethod": null,
            "depositionDate": "2004-02-05T00:00:00+0000",
            "releaseDate": "2004-06-08T00:00:00+0000",
            "sourceOrganism": [
              "Mus musculus"
            ],
            "spaceGroup": null,
            "rFactor": null,
            "entityCount": 3,
            "chainCount": 4,
            "uniqueSequences": 1,
            "isHomomer": true,
            "homomerType": "monomer"
          }
        }
      },
      {
        "@type": "PropertyValue",
        "name": "Resolution",
        "value": 2.13,
        "unitCode": "",
        "description": "X-ray crystallography resolution"
      },
      {
        "@type": "PropertyValue",
        "name": "SourceOrganism",
        "value": "Mus musculus",
        "description": "Organism from which the protein was isolated"
      },
      {
        "@type": "PropertyValue",
        "name": "HomomericStructure",
        "value": true,
        "description": "This is a homomeric monomer"
      },
      {
        "@type": "PropertyValue",
        "name": "HomomerType",
        "value": "monomer",
        "description": "Type of homomeric assembly"
      },
      {
        "@type": "PropertyValue",
        "name": "ChainCount",
        "value": 4,
        "description": "Number of chains in the structure"
      },
      {
        "@type": "PropertyValue",
        "name": "UniqueSequenceCount",
        "value": 1,
        "description": "Number of unique amino acid sequences"
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_A_Sequence",
        "value": "KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV",
        "description": "Amino acid sequence for chain A (length: 227)",
        "chainId": "A",
        "entityId": "1",
        "sequenceLength": 227
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_B_Sequence",
        "value": "KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV",
        "description": "Amino acid sequence for chain B (length: 227)",
        "chainId": "B",
        "entityId": "1",
        "sequenceLength": 227
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_C_Sequence",
        "value": "KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV",
        "description": "Amino acid sequence for chain C (length: 227)",
        "chainId": "C",
        "entityId": "1",
        "sequenceLength": 227
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_D_Sequence",
        "value": "KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV",
        "description": "Amino acid sequence for chain D (length: 227)",
        "chainId": "D",
        "entityId": "1",
        "sequenceLength": 227
      },
      {
        "@type": "PropertyValue",
        "name": "PrimaryCitation",
        "value": "Structural Basis for the Deactivation of the Estrogen-related Receptor {gamma} by Diethylstilbestrol or 4-Hydroxytamoxifen and Determinants of Selectivity.",
        "description": "Primary publication for this structure"
      },
      {
        "@type": "PropertyValue",
        "name": "PublicationDOI",
        "value": "10.1074/jbc.M402195200",
        "description": "DOI of the primary publication"
      },
      {
        "@type": "PropertyValue",
        "name": "Entity_1",
        "value": "Chains: A, B, C, D, Length: 227",
        "description": "Entity 1 information"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterID",
        "value": "2G0H_1",
        "description": "Sequence cluster ID from BLASTClust analysis"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterSize",
        "value": 8,
        "description": "Number of interfaces in this cluster"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMembers",
        "value": [
          "2G0H_1",
          "4OAR_3",
          "4RE8_3",
          "4FN9_1",
          "3P0U_1",
          "3CJW_1",
          "1S9P_1"
        ],
        "description": "List of other interfaces in the same cluster (excluding current interface)"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMethod",
        "value": "BLASTClust sequence clustering",
        "description": "Method used for sequence-based clustering"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMethodOptions",
        "value": "-S 25 -L 0.5 -b F",
        "description": "BLASTClust parameters used for sequence clustering"
      }
    ],
    "hasMolecularFunction": {
      "@type": "DefinedTerm",
      "name": "protein binding",
      "inDefinedTermSet": "http://purl.obolibrary.org/obo/GO_0005515"
    },
    "bioChemInteraction": {
      "@type": "Protein",
      "name": "Homodimer partner for interface 1S9P_5",
      "description": "Homodimer interaction partner in chain nan"
    }
  },
  "additionalProperty": [
    {
      "@type": "PropertyValue",
      "name": "InterfaceSource",
      "value": "QSalign",
      "description": "Source of interface ID: QSalign"
    },
    {
      "@type": "PropertyValue",
      "name": "physio",
      "value": false,
      "description": "Physiological (TRUE) or non-physiological (FALSE)"
    },
    {
      "@type": "PropertyValue",
      "name": "label",
      "value": 0,
      "description": "Numeric label (1=physio, 0=non-physio)"
    },
    {
      "@type": "PropertyValue",
      "name": "PDB_ID",
      "value": "1S9P",
      "description": "Protein Data Bank identifier"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain1",
      "value": "nan",
      "description": "First chain in interface"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain2",
      "value": "nan",
      "description": "Second chain in interface"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain1",
      "value": "nan",
      "description": "First chain in the interface (may be updated from assembly)"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain2",
      "value": "nan",
      "description": "Second chain in the interface (may be updated from assembly)"
    },
    {
      "@type": "PropertyValue",
      "name": "SymmetryOp1",
      "value": "nan",
      "description": "Symmetry operation for chain 1"
    },
    {
      "@type": "PropertyValue",
      "name": "SymmetryOp2",
      "value": "nan",
      "description": "Symmetry operation for chain 2"
    },
    {
      "@type": "PropertyValue",
      "name": "LabelChain1",
      "value": "A",
      "description": "First chain in the assembly interface"
    },
    {
      "@type": "PropertyValue",
      "name": "LabelChain2",
      "value": "D",
      "description": "Second chain in the assembly interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Buried Surface Area (BSA)",
      "value": 1607.28,
      "unitCode": "",
      "description": "Total buried surface area at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Atomic Contacts",
      "value": 47,
      "description": "Number of atomic contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Gene",
      "value": "Esrrg",
      "description": "Gene name associated with the protein"
    },
    {
      "@type": "PropertyValue",
      "name": "Superfamily",
      "value": "1.10.565.10",
      "description": "Protein superfamily classification"
    },
    {
      "@type": "PropertyValue",
      "name": "Pfam",
      "value": "PF00104",
      "description": "Pfam domain classification"
    },
    {
      "@type": "PropertyValue",
      "name": "BSA Polar",
      "value": 408.119999999999,
      "unitCode": "",
      "description": "Polar component of buried surface area"
    },
    {
      "@type": "PropertyValue",
      "name": "BSA Apolar",
      "value": 1199.17,
      "unitCode": "",
      "description": "Apolar component of buried surface area"
    },
    {
      "@type": "PropertyValue",
      "name": "Fraction Polar",
      "value": 0.253919665521874,
      "description": "Fraction of polar contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Fraction Apolar",
      "value": 0.746086556169429,
      "description": "Fraction of apolar contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterID",
      "value": "2G0H_1",
      "description": "Sequence cluster ID from BLASTClust analysis"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterSize",
      "value": 8,
      "description": "Number of interfaces in this cluster"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMembers",
      "value": [
        "2G0H_1",
        "4OAR_3",
        "4RE8_3",
        "4FN9_1",
        "3P0U_1",
        "3CJW_1",
        "1S9P_1"
      ],
      "description": "List of other interfaces in the same cluster (excluding current interface)"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMethod",
      "value": "BLASTClust sequence clustering",
      "description": "Method used for sequence-based clustering"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMethodOptions",
      "value": "-S 25 -L 0.5 -b F",
      "description": "BLASTClust parameters used for sequence clustering"
    }
  ]
}